Gene · 5352
NIH grants805
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 805
Download this page as JSON| Grant | Title | PLOD2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA207772 | Roles of Hsp47 in Breast Cancer Progression | 2 | 2025 |
| R01CA227942 | Targeting the cancer glycocalyx | 2 | 2025 |
| R01GM106137 | Development of a Next-Generation Nucleic Acid Force Field | 2 | 2025 |
| R01HL049277 | Animal Models for Studying the Genetics of Complex Diseases | 2 | 2025 |
| R35GM122481 | Development and Testing of New Computational Methods for Ligand Discovery and Mechanism | 2 | 2025 |
| T32AI060537 | Integrative Microbiology Program | 2 | 2025 |
| T32AR064194 | Rheumatic Diseases Research Training Grant | 2 | 2025 |
| TL1TR001864 | J. NRSA Training Core | 2 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 2 | 2025 |
| U19AI135990 | HPMI: Host Pathogen Mapping Initiative | 2 | 2025 |
| U54AR068069 | Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network | 2 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 2 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 2 | 2025 |
| D43TW010354 | AIDS Malignancies Training and Research International Program (AMTRIP) | 1 | 2025 |
| K12CA133250 | OSU K12 Training Grant in Oncology | 1 | 2025 |
| K12CA215110 | YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM | 1 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 1 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 1 | 2025 |
| P20GM103434 | West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | 1 | 2025 |
| P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/grants?page=2